| Literature DB >> 19157876 |
An-Chi Lo1, Ageliki Georgopoulos, Celina G Kleer, Mousumi Banerjee, Sherif Omar, Hussein Khaled, Saad Eissa, Ahmed Hablas, Hoda G Omar, Julie A Douglas, Sofia D Merajver, Amr S Soliman.
Abstract
Understanding the molecular factors that distinguish inflammatory breast cancer (IBC) from non-IBC is important for IBC diagnosis. We reviewed the records of 48 IBC patients and 64 non-IBC patients from Egypt. We determined RhoC expression and tumor emboli and their relationship to demographic and reproductive characteristics. Compared with non-IBC patients, IBC patients had significantly lower parity (P=0.018) and fewer palpable tumors (P<0.0001). IBC tumors showed RhoC overexpression more frequently than non-IBC tumors (87% vs. 17%, respectively) (P<0.0001). Tumor emboli were significantly more frequent in IBC tumors than non-IBC tumors (Mean+/- SD: 14.1+/-14.0 vs. 7.0+/-12.9, respectively) (P<0.0001). This study illustrates that RhoC overexpression and tumor emboli are more frequent in tumors of IBC relative to non-IBC from Egypt. Future studies should focus on relating epidemiologic factors to molecular features of IBC in this population.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19157876 PMCID： PMC2818070 DOI： 10.1016/j.breast.2008.11.002
Source DB: PubMed Journal: Breast ISSN： 0960-9776 Impact factor: 4.380